Wellell Inc
Wellell Inc. engages in the manufacture and sale of medical supplies in Europe, the United States, Asia, and internationally. The company offers support surface systems, respiratory therapy devices, and other products. It also provides pressure relief mattress; sleep apnea such as auto-adjusting pressure; sleepwell; compression therapy; and pressure relief seating products. In addition, the compa… Read more
Wellell Inc (4106) - Net Assets
Latest net assets as of September 2025: NT$2.45 Billion TWD
Based on the latest financial reports, Wellell Inc (4106) has net assets worth NT$2.45 Billion TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$3.18 Billion) and total liabilities (NT$729.71 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$2.45 Billion |
| % of Total Assets | 77.04% |
| Annual Growth Rate | 7.86% |
| 5-Year Change | 15.07% |
| 10-Year Change | 45.06% |
| Growth Volatility | 15.51 |
Wellell Inc - Net Assets Trend (2002–2024)
This chart illustrates how Wellell Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Wellell Inc (2002–2024)
The table below shows the annual net assets of Wellell Inc from 2002 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$2.42 Billion | +3.54% |
| 2023-12-31 | NT$2.34 Billion | +5.10% |
| 2022-12-31 | NT$2.23 Billion | +7.90% |
| 2021-12-31 | NT$2.06 Billion | -1.99% |
| 2020-12-31 | NT$2.11 Billion | +3.76% |
| 2019-12-31 | NT$2.03 Billion | +0.40% |
| 2018-12-31 | NT$2.02 Billion | +25.73% |
| 2017-12-31 | NT$1.61 Billion | +3.22% |
| 2016-12-31 | NT$1.56 Billion | -6.75% |
| 2015-12-31 | NT$1.67 Billion | -15.04% |
| 2014-12-31 | NT$1.97 Billion | +7.47% |
| 2013-12-31 | NT$1.83 Billion | +16.06% |
| 2012-12-31 | NT$1.58 Billion | +6.21% |
| 2011-12-31 | NT$1.48 Billion | +13.42% |
| 2010-12-31 | NT$1.31 Billion | +2.18% |
| 2009-12-31 | NT$1.28 Billion | +10.08% |
| 2008-12-31 | NT$1.16 Billion | +8.48% |
| 2007-12-31 | NT$1.07 Billion | +13.03% |
| 2006-12-31 | NT$948.94 Million | -0.96% |
| 2005-12-31 | NT$958.15 Million | +10.01% |
| 2004-12-31 | NT$870.98 Million | +12.23% |
| 2003-12-31 | NT$776.06 Million | +69.27% |
| 2002-12-31 | NT$458.47 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Wellell Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 458.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$591.20 Million | 24.45% |
| Common Stock | NT$1.01 Billion | 41.73% |
| Other Comprehensive Income | NT$482.58 Million | 19.96% |
| Other Components | NT$335.11 Million | 13.86% |
| Total Equity | NT$2.42 Billion | 100.00% |
Wellell Inc Competitors by Market Cap
The table below lists competitors of Wellell Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Merko Gida Sanayi ve Ticaret AS
IS:MERKO
|
$37.14 Million |
|
Wellspire Holdings Berhad
KLSE:0271
|
$37.14 Million |
|
Expleo Solutions Limited
NSE:EXPLEOSOL
|
$37.15 Million |
|
eHealth Inc
NASDAQ:EHTH
|
$37.15 Million |
|
Muramoto Electron (Thailand) Public Company Limited
BK:METCO
|
$37.12 Million |
|
The Beachbody Company, Inc.
NYSE:BODI
|
$37.12 Million |
|
Manulife Holdings Bhd
KLSE:1058
|
$37.11 Million |
|
PANTHEON INFRASTR.LS -01
F:56N
|
$37.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wellell Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,335,980,000 to 2,418,001,000, a change of 82,021,000 (3.5%).
- Net income of 115,239,000 contributed positively to equity growth.
- Dividend payments of 80,729,000 reduced retained earnings.
- Other comprehensive income increased equity by 634,639,999.
- Other factors decreased equity by 587,128,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$115.24 Million | +4.77% |
| Dividends Paid | NT$80.73 Million | -3.34% |
| Other Comprehensive Income | NT$634.64 Million | +26.25% |
| Other Changes | NT$-587.13 Million | -24.28% |
| Total Change | NT$- | 3.51% |
Book Value vs Market Value Analysis
This analysis compares Wellell Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.94x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.48x to 0.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | NT$15.16 | NT$22.40 | x |
| 2010-12-31 | NT$15.52 | NT$22.40 | x |
| 2011-12-31 | NT$17.53 | NT$22.40 | x |
| 2012-12-31 | NT$17.92 | NT$22.40 | x |
| 2013-12-31 | NT$19.18 | NT$22.40 | x |
| 2014-12-31 | NT$20.74 | NT$22.40 | x |
| 2015-12-31 | NT$19.91 | NT$22.40 | x |
| 2016-12-31 | NT$18.21 | NT$22.40 | x |
| 2017-12-31 | NT$17.52 | NT$22.40 | x |
| 2018-12-31 | NT$21.05 | NT$22.40 | x |
| 2019-12-31 | NT$20.00 | NT$22.40 | x |
| 2020-12-31 | NT$20.74 | NT$22.40 | x |
| 2021-12-31 | NT$20.32 | NT$22.40 | x |
| 2022-12-31 | NT$21.87 | NT$22.40 | x |
| 2023-12-31 | NT$23.00 | NT$22.40 | x |
| 2024-12-31 | NT$23.84 | NT$22.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wellell Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.77%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.83%
- • Asset Turnover: 0.76x
- • Equity Multiplier: 1.30x
- Recent ROE (4.77%) is below the historical average (10.30%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 22.17% | 11.18% | 1.51x | 1.32x | NT$55.78 Million |
| 2003 | 16.26% | 12.63% | 0.83x | 1.54x | NT$48.61 Million |
| 2004 | 12.71% | 10.96% | 0.83x | 1.40x | NT$23.63 Million |
| 2005 | 11.04% | 9.29% | 0.83x | 1.43x | NT$9.91 Million |
| 2006 | 5.60% | 4.74% | 0.77x | 1.53x | NT$-41.69 Million |
| 2007 | 14.45% | 11.12% | 0.85x | 1.52x | NT$47.19 Million |
| 2008 | 13.19% | 9.35% | 0.92x | 1.54x | NT$36.59 Million |
| 2009 | 16.71% | 13.45% | 0.96x | 1.30x | NT$85.18 Million |
| 2010 | 13.90% | 10.88% | 1.02x | 1.25x | NT$50.67 Million |
| 2011 | 15.78% | 13.30% | 0.90x | 1.32x | NT$85.19 Million |
| 2012 | 13.05% | 10.63% | 0.86x | 1.43x | NT$45.91 Million |
| 2013 | 8.31% | 6.62% | 0.83x | 1.51x | NT$-27.13 Million |
| 2014 | 10.28% | 7.88% | 0.90x | 1.45x | NT$4.79 Million |
| 2015 | 10.11% | 8.37% | 0.81x | 1.50x | NT$1.77 Million |
| 2016 | 7.88% | 6.16% | 0.77x | 1.67x | NT$-32.95 Million |
| 2017 | 7.36% | 5.66% | 0.81x | 1.61x | NT$-42.36 Million |
| 2018 | 5.37% | 5.15% | 0.67x | 1.56x | NT$-93.49 Million |
| 2019 | 4.34% | 4.32% | 0.67x | 1.49x | NT$-114.68 Million |
| 2020 | 4.98% | 5.22% | 0.66x | 1.45x | NT$-105.58 Million |
| 2021 | 4.97% | 4.31% | 0.76x | 1.53x | NT$-103.66 Million |
| 2022 | 7.27% | 6.06% | 0.83x | 1.44x | NT$-60.70 Million |
| 2023 | 6.51% | 5.75% | 0.82x | 1.38x | NT$-81.43 Million |
| 2024 | 4.77% | 4.83% | 0.76x | 1.30x | NT$-126.56 Million |
Industry Comparison
This section compares Wellell Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,270,382,778
- Average return on equity (ROE) among peers: 5.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wellell Inc (4106) | NT$2.45 Billion | 22.17% | 0.30x | $37.12 Million |
| Health & Life Co., Ltd. (1781) | $372.58 Million | -4.71% | 1.15x | $12.97 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Radiant Innovation (3373) | $865.89 Million | -3.30% | 0.08x | $18.65 Million |
| Rossmax International Ltd (4121) | $1.33 Billion | 1.93% | 1.30x | $38.32 Million |
| United Orthopedic (4129) | $1.77 Billion | 7.55% | 0.46x | $300.33 Million |
| Dynamic Medical Technologies (4138) | $1.76 Billion | 11.67% | 0.71x | $39.41 Million |
| Ok Biotech Co Ltd (4155) | $1.30 Billion | 9.66% | 0.71x | $44.61 Million |
| Bioptik Technology (4161) | $717.83 Million | 6.76% | 1.11x | $30.42 Million |
| EPS Bio Technology Corp. (4183) | $309.15 Million | 10.25% | 0.77x | $4.27 Million |